Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy (Forest)
This study has been withdrawn prior to enrollment.
( our site was unable to enroll any qualified subjects )
Study NCT00986115   Information provided by University of California, Davis

First Received on September 25, 2009.   Last Updated on October 17, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsy
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Interventions listed in this trial
Memantine
Placebo
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Michael A. Rogawski, MD, PhD
Forest Laboratories


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services